GLOW
EVO Labs proprietary skin and anti-aging blend. GLOW combines GHK-CU, BPC-157, and TB-500 for synergistic collagen stimulation, dermal repair, and cellular regeneration studied in aesthetic and wound-healing research models.
Compound Profile
Pharmaceutical Data Sheet
Mechanism of Action
How GLOW Works
GLOW combines three peptides targeting different phases of skin and tissue regeneration: GHK-Cu drives collagen remodeling and antioxidant gene expression, BPC-157 promotes vascular supply to skin tissue, and TB-500 accelerates dermal cell migration and reduces scarring. Together they support comprehensive skin repair from the vascular to the extracellular matrix level.
- Activates 4,000+ genes for tissue remodeling
- Stimulates collagen I/III and decorin synthesis
- Upregulates antioxidant enzymes (SOD, catalase)
- VEGFR2-driven angiogenesis to skin tissue
- Enhances nutrient and oxygen delivery
- Supports wound healing in dermal injury models
- Promotes keratinocyte migration for wound closure
- Reduces scar formation via anti-fibrotic activity
- Accelerates re-epithelialization
GHK-Cu activates over 4,000 genes involved in tissue remodeling, including collagen I/III synthesis and decorin expression. BPC-157 drives angiogenesis to support nutrient delivery, while TB-500 promotes keratinocyte and fibroblast migration. This three-layer approach addresses dermal repair at the gene expression, vascular, and cellular migration levels.
EVO Labs Research formulation based on individually published dermal repair mechanisms.
Preclinical Findings
Research Models
Clinical Data
Dermal Regeneration Research Blend
GLOW combines three peptides with individual evidence in dermal repair. GHK-Cu has the most extensive skin-specific data, including human cosmetic studies showing wrinkle reduction and skin thickness improvement.
Individual component citations — see GHK-Cu, BPC-157 research pages.
Preclinical and cosmetic clinical data for components
Research Outcomes
Key Research Success Metrics
Safety Profile
Research Safety Notes
- GHK-Cu: naturally occurring peptide in human plasma — excellent safety profile
- BPC-157: No LD50 established — exceptional safety ceiling
- TB-500: Well-tolerated in wound healing studies
- All components are endogenous or derived from endogenous sequences
- Topical and subcutaneous routes studied independently for each component
GLOW is a proprietary blend. Safety and efficacy data derives from individual component research. For research use only.
About GLOW
EVO Labs proprietary skin and anti-aging blend. GLOW combines GHK-CU, BPC-157, and TB-500 for synergistic collagen stimulation, dermal repair, and cellular regeneration studied in aesthetic and wound-healing research models.
All EVO Labs Research compounds are manufactured to research-grade standards and independently tested by Janoshik Analytical (Prague, est. 2013). The Certificate of Analysis for this compound includes full HPLC chromatography data, mass spectrometry confirmation, net purity percentage, and net content verification.
Research Use Only
This product is strictly for in vitro research and laboratory use only. Not for human or veterinary consumption. By purchasing, you confirm use in a controlled research setting.
